T) 03-Nov-15 R&D Investor day to update on pharmaceutical and vaccine pipelines 4016 Mepolizumab US regulatory decision in severe asthma 2015 Mosquirix EMA approval decision on malaria vaccine 2015 Sartakumab Phase Ill data in rheumatoid arthritis IRA) 2015 Investigation Possible outcome of SF